Same Indication

Ipilimumab vs Lansoprazole

Ipilimumab vs Lansoprazole: Overview

This comparison examines the pharmacological differences between Ipilimumab and Lansoprazole.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Lansoprazole: Proton pump inhibitor.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Lansoprazole — 1.5 hours.

Chemical Properties

Molecular Formula: Lansoprazole — C16H14F3N3O2S.

Molecular Weight: Lansoprazole — 369.3620 g/mol.

Type: Ipilimumab — Antibody; Lansoprazole — Small molecule.